AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Anika Therapeutics, Inc. Director's Dealing 2020

Jul 10, 2020

33997_dirs_2020-07-10_68527d12-abff-4ecd-843c-1022dde60002.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Anika Therapeutics, Inc. (ANIK)
CIK: 0000898437
Period of Report: 2020-07-08

Reporting Person: Loerop James (EVP Business Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-07-08	Common Stock	A	3000	—	Acquired	3000	Direct
2020-07-09	Common Stock	S	1244	$35.15	Disposed	1756	Direct

Footnotes

F1: Reflects the first vesting installment of RSUs granted on July 8, 2019.

F2: Reflects an aggregate of 1,244 shares of common stock sold by Mr. Loerop to satisfy tax withholding obligations with respect to RSUs that vested on July 8, 2020.

F3: On July 9, 2020, Mr. Loerop sold 1,244 shares in one trade for $35.15.